Largely in agreement with our findings, the expression of CEP55 has been reported to be 9‐fold higher when compared with adjacent normal tissues, which is associated with advanced tumour stage and a higher risk of lymph node metastasis in patients with cervical cancer.6 Here, CEP55 is linked to cervical carcinoma.